- 2 -
- 3 -
Over the past 30 years, more than 1.2 billion tablets and over 30,000 metric
tons of liquids have been produced at the Kiel site. If lined up one after an-
other, all the pipettes of animal health products manufactured so far would
stretch around the Earth. Today more than 360 KVP employees produce about
50 percent of all animal health products sold by Bayer worldwide. With a me-
dium-sized, independent corporate structure, KVP is the biggest manufactur-
ing and logistics site of Bayer HealthCare AG's Animal Health Division a
market that enjoys steady growth rates in both Europe and (North) America.
"In the past 10 years alone, we have increased the size of our workforce from
260 to more than 360. Thus we are a permanent fixture of both the labor mar-
ket in Kiel and the vocational training market," says Olaf Assenheimer, who
became Managing Director of KVP GmbH in 2002. Assenheimer describes
his company as a "successful, competitive, medium-sized international sup-
plier from Kiel backed by a strong parent company."
Adds Assenheimer confidently: "The FDA certification will allow us to se-
cure and expand our competitive position in the very important U.S. market
and to continue our success story."
KVP supplies more than 100 countries around the world with 150 products in
about 800 presentations as animal health products and also with veterinary
nutrition and grooming products. From ointments, creams and pastes through
tablets, powders and granules to liquids, suspensions, emulsions and aerosols:
KVP has a perfect command of both production and the important logistics
process. The company directly ships essential products to veterinarians in
Germany within 24 hours.
Among the products manufactured by KVP are: Advantage
®
pipettes for spot-
on antiparasitic treatment; the non-prescription antibiotic Baytril
®
; Baycox
®
to fight infections in small and large animals; Drontal and Droncit to control
